Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Cardiac regeneration in 2017

Novel paradigms in the fight against heart failure

Nature Reviews Cardiology volume 15, pages 73–74 (2018)Cite this article

Subjects

Important milestones in cardiac regenerative medicine that will define future research were reached in 2017: demonstration of adult cardiomyocyte renewal capacity, recognition of the importance of the extracellular matrix and the higher regenerative efficacy of repetitive dose protocols, and the publication of human data supporting paracrine effects of stem cell therapies and guidelines from TACTICS, the first international alliance on cardiac regenerative medicine.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: 2017 insights for the evolution of cardiac regenerative medicine.

References

  1. Lázár, E., Sadek, H. A. & Bergmann, O. Cardiomyocyte renewal in the human heart: insights from the fall-out. Eur. Heart J. 38, 2333–2342 (2017).

    Article  Google Scholar 

  2. Wang, W. E. et al. Dedifferentiation, proliferation, and redifferentiation of adult mammalian cardiomyocytes after ischemic injury. Circulation 136, 834–848 (2017).

    Article  Google Scholar 

  3. Bassat, E. et al. The extracellular matrix protein agrin promotes heart regeneration in mice. Nature 547, 179–184 (2017).

    Article  CAS  Google Scholar 

  4. Guo, Y. et al. Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res. Cardiol. 112, 18 (2017).

    Article  Google Scholar 

  5. Wollert, K. C. et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial. Eur. Heart J. 38, 2936–2943 (2017).

    Article  CAS  Google Scholar 

  6. Fernández-Avilés, F. et al. Global position paper on cardiovascular regenerative medicine. Eur. Heart J. 38, 2532–2546 (2017).

    Article  Google Scholar 

Download references

Acknowledgements

The author thanks Andreu Climent, Ricardo Sanz-Ruiz, and Ana Fernández-Baza for their outstanding contribution to this work. F.F.-A. is supported by grants from the Spanish Ministry of Science and Innovation (RTC-2015–4398, RTC- 2016–4911), Instituto de Salud Carlos III (PI13- 01882 and PI16-01123), Red de Investigación Cardiovascular (RIC. RD12.0042.0001), Red de Terapia Celular (TERCEL. RD12.0019.0021), and CIBERCV (CB16-11-00292), and is co-financed with FEDER funds.

Author information

Authors and Affiliations

  1. Francisco Fernández-Avilés is at the Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERCV, calle del Doctor Esquerdo 46, 28007 Madrid, Spain.,

    Francisco Fernández-Avilés

Authors
  1. Francisco Fernández-Avilés
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francisco Fernández-Avilés.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Related links

FURTHER INFORMATION

TACTICS Alliance

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernández-Avilés, F. Novel paradigms in the fight against heart failure. Nat Rev Cardiol 15, 73–74 (2018). https://doi.org/10.1038/nrcardio.2017.218

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2017.218

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research